Structure of pathological TDP-43 filaments from ALS with FTLD

被引:0
|
作者
Diana Arseni
Masato Hasegawa
Alexey G. Murzin
Fuyuki Kametani
Makoto Arai
Mari Yoshida
Benjamin Ryskeldi-Falcon
机构
[1] MRC Laboratory of Molecular Biology,Department of Brain and Neurosciences
[2] Tokyo Metropolitan Institute of Medical Science,Department of Psychiatry and Behavioural Sciences
[3] Tokyo Metropolitan Institute of Medical Science,Institute for Medical Science of Aging
[4] Aichi Medical University,undefined
来源
Nature | 2022年 / 601卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD)1,2. It is also common in other diseases, including Alzheimer’s and Parkinson’s. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282–360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro3,4. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.
引用
收藏
页码:139 / 143
页数:4
相关论文
共 50 条
  • [1] Structure of pathological TDP-43 filaments from ALS with FTLD
    Arseni, Diana
    Hasegawa, Masato
    Murzin, Alexey G.
    Kametani, Fuyuki
    Arai, Makoto
    Yoshida, Mari
    Ryskeldi-Falcon, Benjamin
    NATURE, 2022, 601 (7891) : 139 - +
  • [2] The role of TDP-43 in the pathogenesis of ALS and FTLD
    Baralle, Marco
    Buratti, Emanuele
    Baralle, Francisco E.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1536 - 1540
  • [3] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8
  • [4] ALS and FTLD: two faces of TDP-43 proteinopathy
    Liscic, R. M.
    Grinberg, L. T.
    Zidar, J.
    Gitcho, M. A.
    Cairns, N. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) : 772 - 780
  • [5] Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
    Tamaki, Yoshitaka
    Urushitani, Makoto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [6] NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
    Amanda M. Gleixner
    Brandie Morris Verdone
    Charlton G. Otte
    Eric N. Anderson
    Nandini Ramesh
    Olivia R. Shapiro
    Jenna R. Gale
    Jocelyn C. Mauna
    Jacob R. Mann
    Katie E. Copley
    Elizabeth L. Daley
    Juan A. Ortega
    Maria Elena Cicardi
    Evangelos Kiskinis
    Julia Kofler
    Udai B. Pandey
    Davide Trotti
    Christopher J. Donnelly
    Nature Communications, 13
  • [7] NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
    Gleixner, Amanda M.
    Verdone, Brandie Morris
    Otte, Charlton G.
    Anderson, Eric N.
    Ramesh, Nandini
    Shapiro, Olivia R.
    Gale, Jenna R.
    Mauna, Jocelyn C.
    Mann, Jacob R.
    Copley, Katie E.
    Daley, Elizabeth L.
    Ortega, Juan A.
    Cicardi, Maria Elena
    Kiskinis, Evangelos
    Kofler, Julia
    Pandey, Udai B.
    Trotti, Davide
    Donnelly, Christopher J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [8] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181
  • [9] TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
    Arseni, Diana
    Chen, Renren
    Murzin, Alexey G.
    Peak-Chew, Sew Y.
    Garringer, Holly J.
    Newell, Kathy L.
    Kametani, Fuyuki
    Robinson, Andrew C.
    Vidal, Ruben
    Ghetti, Bernardino
    Hasegawa, Masato
    Ryskeldi-Falcon, Benjamin
    NATURE, 2023, 620 (7975) : 898 - 903
  • [10] TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
    Diana Arseni
    Renren Chen
    Alexey G. Murzin
    Sew Y. Peak-Chew
    Holly J. Garringer
    Kathy L. Newell
    Fuyuki Kametani
    Andrew C. Robinson
    Ruben Vidal
    Bernardino Ghetti
    Masato Hasegawa
    Benjamin Ryskeldi-Falcon
    Nature, 2023, 620 : 898 - 903